FDA Inspection 1216081 — Barbara L. Smith, MD, PhD.

Barbara L. Smith, MD, PhD. — FEI 3027328613

The FDA completed an inspection of Barbara L. Smith, MD, PhD. on August 4, 2023 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 4, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Clinical Investigator (CI)